Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 22Sanofi
02 32care4
03 1Acino Pharma
04 1Actavis Inc
05 4Advanced Group
06 1Alexon Healthcare
07 8Alphapharm PTY Ltd
08 2Antibiotice
09 1Anwita Drugs
10 2Atabay
11 1Avet Pharmaceuticals
12 2Bausch Health
13 1Central Procurement & Supplies Unit
14 2Chartwell Pharmaceuticals llc
15 2Chongqing Huapont Pharmaceutical
16 1Deva Holding AS
17 3Epic Pharma. LLC.
18 1Fresenius Kabi USA
19 5Hikma Pharmaceuticals
20 1Indo Pharma
21 6Labatec Pharm
22 2Lupin Ltd
23 7Macleods Pharmaceuticals Limited
24 3Medicine Developers International CC
25 1Medivision
26 4Novartis Pharmaceuticals Corporation
27 2ORIFARM GROUP AS
28 1Oxford Pharm
29 3Pannon
30 1Paranova Group AS
31 2Pfizer Inc
32 6Pharma Dynamics
33 4Polfa Tarchomin
34 1Reyoung pharmaceutical
35 52Sandoz B2B
36 1Shenyang Shuangding Pharmaceutical
37 3Umedica Laboratories
38 2Varichem Pharmaceuticals Pvt Ltd
39 1Viatris
01 2CAP
02 6CAPSULE
03 13CAPSULE;ORAL
04 13Capsule
05 4Capsule And Tablet
06 2Coated Tablet
07 23Film Coated Tablet
08 6Hard Capsule
09 3Hard Capsules
10 1INF
11 8INJECTABLE;INJECTION
12 1Injectable (Lyophilized Powder)
13 4Injection
14 1Isoniazid+Pyrazinamide+Rifampicin 50+300+120Mg 40 Combined Oral Use
15 1Oral Suspension
16 1PELLET
17 1Powder And Solvent For Infusion Solution
18 1Powder for Injection
19 1Rifampicin 2% 60Ml Oral Use
20 1Rifampicin 300Mg 8 Joined' Oral Use
21 1Rifampicin 450Mg 8 Joined' Oral Use
22 1Rifampicin 600Mg 1 Unit Parenteral Use
23 1Rifampicin+Isoniazid+150300 Mg 24 Units Of Oral Use
24 1Rifampicin+Isoniazid+Pyrazinamide+Ethambutol 150+75+400+275Mg 60 Units Oral Use
25 1SUS
26 1SUSPENSION
27 2Solution For Injection
28 1Suspension
29 50TAB
30 1TABLET;ORAL
31 1Tab
32 4capsule
33 2capsules
34 1oral
35 5Blank
01 16Allowed
02 2Authorised
03 7Authorized
04 9DISCN
05 3Dossier Availability: Q4 2026
06 63Generic
07 5Marketed
08 3Not Marketed
09 9Prescription
10 13RX
11 2Withdrawn
12 34Blank
01 1Afaris FC 150/75
02 1Afaris FC 300/150
03 1Afaris Paed 75/50
04 3Antib-4
05 1Co-Afaris Paed 75/50/150
06 1Ebsar-2 DS
07 1Ftizamax
08 1MDT-Combi MB Children
09 1MDT-Combi MB Erwachsene und Jugendliche
10 1MDT-Combi PB Adults and Adolescents
11 1MDT-Combi PB Children
12 1Macox
13 1R-Cin 600
14 2R-Cin Plus
15 1R-Cin Suspension
16 3RIFADIN
17 1RIFAMATE
18 15RIFAMPIN
19 1RIFAMPIN AND ISONIAZID
20 1RIFATER
21 2RIFEX
22 1RIMACTANE
23 2ROFACT
24 1Rifabact
25 2Rifacure
26 5Rifadin
27 3Rifaldin
28 2Rifamazid,
29 2Rifamed
30 4Rifampicin Labatec
31 2Rifampicin Labatec iv
32 1Rifampicin with Isoniazid
33 2Rifampicin-Ferein
34 1Rifampicin/Isoniazid
35 1Rifampicin/Isoniazid/Pyrazinamide/Ethambutol Hydrochloride
36 1Rifamps
37 2Rifater
38 1Rifater Coated Tablets
39 1Rifazid
40 5Rifinah
41 1Rifinah-300
42 3Rimactan
43 7Rimactane
44 1Rimactane 150
45 1Rimactane 300 Vial
46 1Rimactane 450
47 1Rimactane 600
48 4Rimactazid
49 3Rimactazid 150/75
50 1Rimactazid 150/75 Tablets
51 1Rimactazid 300/150
52 4Rimactazid Paed 60/30
53 4Rimactazid Paed 60/60
54 1Rimcure
55 9Rimcure Paed 3-Fdc
56 5Rimstar
57 9Rimstar 4-Fdc
58 1Rimstar Film-Coated Tablets
59 2Rimtib Tablets
60 4Rimycin 150
61 4Rimycin 300
62 3Risopet
63 1Rstar
64 2SINERDOL®
65 3URIFA
66 10Blank
01 9Australia
02 2Canada
03 4China
04 7Denmark
05 3Hungary
06 5India
07 7Italy
08 4Malta
09 3Moldova
10 8Norway
11 3Poland
12 2Romania
13 4Russia
14 55South Africa
15 7Spain
16 16Switzerland
17 3Turkey
18 22USA
19 2Zimbabwe
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RIFADIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50420
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RIFADIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50420
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIFADIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 600MG/VIAL
Packaging :
Approval Date : 1989-05-25
Application Number : 50627
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
Brand Name : RIFATER
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG;300MG;120MG
Packaging :
Approval Date : 1994-05-31
Application Number : 50705
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RIFAMATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG;300MG
Packaging :
Approval Date : 1982-01-01
Application Number : 61884
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Isoniazid; Pyrazinamide; Rifampin
Brand Name : Rifater
Dosage Form : Isoniazid+Pyrazinamide+Rifampicin 50+300+120Mg 40 Combined Oral Use
Dosage Strength : 40 cpr riv 50 mg + 300mg + 120 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 2% 60Ml Oral Use
Dosage Strength : 1 bottle 60 ml 20 mg/ml syrup
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 300Mg 8 Joined' Oral Use
Dosage Strength : 8 cps 300 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 450Mg 8 Joined' Oral Use
Dosage Strength : 8 cpr riv 450 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 600Mg 1 Unit Parenteral Use
Dosage Strength : 1 ampoule EV 600 mg + 1 ampoule solv 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifinah
Dosage Form : Rifampicin+Isoniazid+150300 Mg 24 Units Of Oral Use
Dosage Strength : 24 cpr riv 300 mg + 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rifinah
Dosage Form : Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 18/09/1975
Application Number : 38931
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Rifampicin; Isoniazid; Pyrazinamide
Brand Name : Rifater
Dosage Form : Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 17/02/1986
Application Number : 47063
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG; 300MG
Packaging :
Approval Date : 2007-08-08
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG; 150MG
Packaging :
Approval Date : 2011-03-14
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Isoniazide; Pyrazinamide; Rifampicin
Brand Name : Rifater Coated Tablets
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 01-04-1989
Application Number : 58299
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 300MG; 150 MG
Packaging :
Approval Date : 01-09-1978
Application Number : 54213
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifaldin
Dosage Form : Oral Suspension
Dosage Strength : 20MG
Packaging :
Approval Date : 01-06-1968
Application Number : 46028
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifaldin
Dosage Form : Capsule
Dosage Strength : 300MG
Packaging :
Approval Date : 01-06-1968
Application Number : 46029
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifaldin
Dosage Form : Powder And Solvent For Infusion Solution
Dosage Strength : 600MG
Packaging :
Approval Date : 01-03-1986
Application Number : 56487
Regulatory Info : Authorized
Registration Country : Spain
